Effects of Pharmacological GIP Infusion on Insulin, Glucagon, and Cardiovascular Responses During Hyperglycemia in Type 2 Diabetes.
Yixuan Sun, Cong Xie, Weikun Huang et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial investigated the effects of intravenous GIP infusion on glucose homeostasis and cardiovascular responses in ten individuals with type 2 diabetes. The study found that GIP significantly increased insulin and C-peptide responses, elevated glucose infusion requirements, and augmented heart rate while reducing blood pressure. Notably, GIP also attenuated glucagon suppression and decreased insulin sensitivity.
Key findings
- GIP infusion increased insulin response to 8,717 mU/L*min compared to 3,074 mU/L*min with saline (P = 0.003).
- C-peptide response was elevated to 383.1 nmol/L*min with GIP versus 185.0 nmol/L*min with saline (P = 0.0005).
- Glucose infusion requirements rose to 6.1 mg/kg/min with GIP compared to 4.9 mg/kg/min with saline (P = 0.02).
- GIP infusion increased heart rate and reduced systolic and diastolic blood pressures (P < 0.01 each).
Why it matters
Understanding the effects of GIP on glucose metabolism and cardiovascular responses is crucial for managing type 2 diabetes, especially as new therapies targeting GIP receptors are developed. This study highlights GIP's potential role in influencing both metabolic and cardiovascular outcomes.